Formulation and evaluation of a novel cubosomal emulgel for topical delivery of luliconazole
- 15 July 2022
- journal article
- research article
- Published by Walter de Gruyter GmbH in Tenside Surfactants Detergents
- Vol. 59 (5), 373-382
- https://doi.org/10.1515/tsd-2022-2442
Abstract
Despite numerous remarkable developments in clinical therapy, the world remains firmly in the grip of fungal infections. While conventional approaches to antifungal therapy are failing, dermatophytes continue to affect people’s daily lives, especially in humid and tropical areas, and pose a major medical problem. Cubosomes, the liquid crystalline nanostructures, are among the recently developed lipid nanoparticles that could potentially overcome the hurdles of conventional therapy. In the present study, cubosomes containing luliconazole, an antifungal drug, were formulated to overcome the limitation of poor water solubility and poor bioavailability of the drug for the main purpose of treating fungal infections. Various formulations of luliconazole loaded cubosomes were prepared with different ratios of lipid (glyceryl monooleate) and surfactant (poloxamer 407) using emulsification method. The prepared formulations were optimised and the optimised cubosomal dispersion was loaded into a carbomer-934 gel to form an emulsifying gel. All cubosomal dispersions had particle sizes ranging from 124 nm to 221.1 nm, optimal zeta potential and polydispersity index, and were found to be stable. The drug entrapment efficiency of the cubosomes was over 90%. The in vitro diffusion study showed that the developed formulation had a higher release rate than the marketed formulation. The in vitro antifungal activity study confirmed that the prepared emulsion formulation was also effective against Candida albicans. The novel drug delivery system developed in this study, the cubosomal emulgel, could thus be a favourable approach for the topical delivery of luliconazole for the treatment of fungal infections.Keywords
This publication has 14 references indexed in Scilit:
- A review on cubosome: The novel drug delivery systemGSC Biological and Pharmaceutical Sciences, 2018
- Topical Delivery of Erythromycin Through Cubosomes for AcnePharmaceutical Nanotechnology, 2018
- FORMULATION AND EVALUATION OF TOPICAL EMULGEL OF KETOCONAZOLE BY CUBOSOMAL TECHNIQUEWorld Journal of Pharmaceutical Research, 2017
- Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studiesDrug Delivery, 2017
- Luliconazole for the treatment of fungal infections: an evidence-based reviewCore Evidence, 2014
- Treatment of cutaneous candidiasis through fluconazole encapsulated cubosomesDrug Delivery and Translational Research, 2014
- Cubic phase nanoparticles for sustained release of ibuprofen formulation characterization and enhanced bioavailability studyInternational Journal of Nanomedicine, 2013
- APPLICATIONS OF NANOTECHNOLOGY IN PHARMACEUTICAL DEVELOPMENTPublished by Elsevier BV ,2012
- In vitroantifungal activities of luliconazole, a new topical imidazoleMedical Mycology, 2009
- Cubosomes: An OverviewBiological & Pharmaceutical Bulletin, 2007